{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:11:34Z","timestamp":1770822694392,"version":"3.50.1"},"reference-count":34,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"abstract":"<jats:p>\n                    <jats:italic>Context<\/jats:italic>\n                    .\u2014The association of certain types of human papillomavirus with cervical carcinoma is well established. Human papillomavirus testing is now routinely used to screen for cervical carcinoma and precursor lesions of the cervix (cotesting and reflex testing) and these results are considered in patient triage and management.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Objective<\/jats:italic>\n                    .\u2014To provide information about current laboratory practices in human papillomavirus testing and consensus best practice statements based on results from the College of American Pathologists' laboratory-based survey funded by the Centers for Disease Control and Prevention.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Design<\/jats:italic>\n                    .\u2014The College of American Pathologists submitted a paper-based survey to 1245 laboratories in the United States. After review of the initial results, follow-up Web-based survey results, and a literature review by an expert working group, consensus best practice statements were constructed by working group members for presentation at a national consensus conference. These best practice statements were discussed and then voted upon by conference participants.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Results<\/jats:italic>\n                    .\u2014A total of 525 laboratories responded to survey questions about human papillomavirus ordering and monitoring practices, whereas 546 responded to the overall survey. In most laboratories (87.6%), the high-risk human papillomavirus test is ordered as a reflex test by providers. A minority of laboratories (11.9%) routinely bundle low- and high-risk human papillomavirus tests. Most laboratories (84.4%) do not limit testing in patients with atypical squamous cells to women older than 20 years. More than half of laboratories (53.3%) monitor human papillomavirus positive rates in Papanicolaou tests with atypical squamous cells of undetermined significance.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusions<\/jats:italic>\n                    .\u2014It is not appropriate for laboratories to offer low-risk human papillomavirus testing for any clinical circumstance in gynecologic cytology. Laboratories should not order human papillomavirus testing to resolve diagnostic discrepancies. It is a valuable broad measure of laboratory quality to monitor the human papillomavirus\u2013positive rates in Papanicolaou tests with atypical squamous cells.\n                  <\/jats:p>","DOI":"10.5858\/arpa.2012-0114-cp","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T13:59:27Z","timestamp":1359640767000},"page":"214-219","source":"Crossref","is-referenced-by-count":8,"title":["Monitoring and Ordering Practices for Human Papillomavirus in Cervical Cytology: Findings From the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference Working Group 5"],"prefix":"10.5858","volume":"137","author":[{"given":"Christine N.","family":"Booth","sequence":"first","affiliation":[{"name":"From the Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dr Booth); the College of American Pathologists, Northfield, Illinois (Mss Bashleben and Souers); Duke Raleigh Hospital and Duke University, Raleigh, North Carolina (Dr Filomena); the Cytotechnology Program, University of Kansas Medical Center, Kansas City (Dr Means); the Division of Cytopathology, North Shore\u2013Long Island Jewish Health System, New Hyde Park, New York (Dr Wasserman); and the Department of..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Bashleben","sequence":"additional","affiliation":[{"name":"From the Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dr Booth); the College of American Pathologists, Northfield, Illinois (Mss Bashleben and Souers); Duke Raleigh Hospital and Duke University, Raleigh, North Carolina (Dr Filomena); the Cytotechnology Program, University of Kansas Medical Center, Kansas City (Dr Means); the Division of Cytopathology, North Shore\u2013Long Island Jewish Health System, New Hyde Park, New York (Dr Wasserman); and the Department of..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol A.","family":"Filomena","sequence":"additional","affiliation":[{"name":"From the Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dr Booth); the College of American Pathologists, Northfield, Illinois (Mss Bashleben and Souers); Duke Raleigh Hospital and Duke University, Raleigh, North Carolina (Dr Filomena); the Cytotechnology Program, University of Kansas Medical Center, Kansas City (Dr Means); the Division of Cytopathology, North Shore\u2013Long Island Jewish Health System, New Hyde Park, New York (Dr Wasserman); and the Department of..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilee M.","family":"Means","sequence":"additional","affiliation":[{"name":"From the Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dr Booth); the College of American Pathologists, Northfield, Illinois (Mss Bashleben and Souers); Duke Raleigh Hospital and Duke University, Raleigh, North Carolina (Dr Filomena); the Cytotechnology Program, University of Kansas Medical Center, Kansas City (Dr Means); the Division of Cytopathology, North Shore\u2013Long Island Jewish Health System, New Hyde Park, New York (Dr Wasserman); and the Department of..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia G.","family":"Wasserman","sequence":"additional","affiliation":[{"name":"From the Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dr Booth); the College of American Pathologists, Northfield, Illinois (Mss Bashleben and Souers); Duke Raleigh Hospital and Duke University, Raleigh, North Carolina (Dr Filomena); the Cytotechnology Program, University of Kansas Medical Center, Kansas City (Dr Means); the Division of Cytopathology, North Shore\u2013Long Island Jewish Health System, New Hyde Park, New York (Dr Wasserman); and the Department of..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhona J.","family":"Souers","sequence":"additional","affiliation":[{"name":"From the Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dr Booth); the College of American Pathologists, Northfield, Illinois (Mss Bashleben and Souers); Duke Raleigh Hospital and Duke University, Raleigh, North Carolina (Dr Filomena); the Cytotechnology Program, University of Kansas Medical Center, Kansas City (Dr Means); the Division of Cytopathology, North Shore\u2013Long Island Jewish Health System, New Hyde Park, New York (Dr Wasserman); and the Department of..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Henry","sequence":"additional","affiliation":[{"name":"From the Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dr Booth); the College of American Pathologists, Northfield, Illinois (Mss Bashleben and Souers); Duke Raleigh Hospital and Duke University, Raleigh, North Carolina (Dr Filomena); the Cytotechnology Program, University of Kansas Medical Center, Kansas City (Dr Means); the Division of Cytopathology, North Shore\u2013Long Island Jewish Health System, New Hyde Park, New York (Dr Wasserman); and the Department of..."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","reference":[{"key":"i1543-2165-137-2-214-b01","series-title":"Fed Regist","first-page":"7001","article-title":"Final Rule","volume":"57","year":"1992","unstructured":"Clinical Laboratory Improvement Amendments of 1988. Final Rule. Fed Regist. 1992;57:7001\u20137186. Current CLIA regulations (including all changes through 01\/24\/2004).http:\/\/www.phppo.cdc.gov\/clia\/regs\/toc.aspx. Accessed June 7, 2012."},{"issue":"4","key":"i1543-2165-137-2-214-b02","series-title":"J Low Genit Tract Dis","first-page":"201","article-title":"2006 consensus guidelines for the management of women with abnormal cervical screening tests","volume":"11","author":"Wright\n              TC\n              Jr,","year":"2007","unstructured":"Wright\n              TC\n              Jr, \n            \n              Massad\n              LS, \n            \n              Dunton\n              CJ, \n            \n              Spitzer\n              M, \n            \n              Wilkinson\n              EJ, \n            \n              Solomon\n              D. \n          \n          2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis. 2007;11(4):201\u2013222."},{"issue":"3","key":"i1543-2165-137-2-214-b03","series-title":"J Low Genit Tract Dis","first-page":"135","article-title":"Davis Davey D. Statement on HPV DNA test utilization","volume":"13","author":"Solomon\n              D,","year":"2009","unstructured":"Solomon\n              D, \n            \n              Papillo\n              J, \n          \n          Davis Davey D. Statement on HPV DNA test utilization. J Low Genit Tract Dis. 2009;13(3):135\u2013136."},{"issue":"2","key":"i1543-2165-137-2-214-b04","series-title":"Arch Pathol Lab Med","first-page":"158","article-title":"College of American Pathologists consensus conference on good laboratory practices in gynecologic cytology: background, rationale, and organization","volume":"137","author":"Tworek\n              JA,","year":"2013","unstructured":"Tworek\n              JA, \n            \n              Henry\n              M, \n            \n              Jones\n              BA. \n          \n          College of American Pathologists consensus conference on good laboratory practices in gynecologic cytology: background, rationale, and organization. Arch Pathol Lab Med. 2013;137(2):158\u2013163."},{"issue":"2","key":"i1543-2165-137-2-214-b05","series-title":"J Pediatr","first-page":"277","article-title":"The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women","volume":"132","author":"Moscicki\n              AB,","year":"1998","unstructured":"Moscicki\n              AB, \n            \n              Shiboski\n              S, \n            \n              Broering\n              J, \n            et al\n          . The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr. 1998;132(2):277\u2013284."},{"issue":"8","key":"i1543-2165-137-2-214-b06","series-title":"Diagn Cytopathol","first-page":"463","article-title":"A rock and a hard place: HPV testing and financial gain","volume":"35","author":"Moriarty\n              AT.","year":"2007","unstructured":"Moriarty\n              AT. \n          \n          A rock and a hard place: HPV testing and financial gain. Diagn Cytopathol. 2007;35(8):463\u2013464."},{"issue":"3","key":"i1543-2165-137-2-214-b07","series-title":"Obstet Gynecol","first-page":"595","article-title":"Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting","volume":"113","author":"Castle\n              PE,","year":"2009","unstructured":"Castle\n              PE, \n            \n              Fetterman\n              B, \n            \n              Poitras\n              N, \n            \n              Lorey\n              T, \n            \n              Shaber\n              R, \n            \n              Kinney\n              W. \n          \n          Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting. Obstet Gynecol. 2009;113(3):595\u2013600."},{"issue":"7","key":"i1543-2165-137-2-214-b08","series-title":"Ann Intern Med","first-page":"493","article-title":"Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003\u20132005","volume":"148","author":"Datta\n              SD,","year":"2008","unstructured":"Datta\n              SD, \n            \n              Koutsky\n              LA, \n            \n              Ratelle\n              S, \n            et al\n          . Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003\u20132005. Ann Intern Med. 2008;148(7):493\u2013500."},{"issue":"6","key":"i1543-2165-137-2-214-b09","series-title":"Am J Clin Pathol","first-page":"894","article-title":"High-risk HPV testing in women 30 years or older with negative Papanicolaou tests: initial clinical experience with 18-month follow-up","volume":"133","author":"Thrall\n              MJ,","year":"2010","unstructured":"Thrall\n              MJ, \n            \n              Russell\n              DK, \n            \n              Facik\n              MS, \n            et al\n          . High-risk HPV testing in women 30 years or older with negative Papanicolaou tests: initial clinical experience with 18-month follow-up. Am J Clin Pathol. 2010;133(6):894\u2013898."},{"issue":"1","key":"i1543-2165-137-2-214-b10","series-title":"Acta Cytol","first-page":"48","article-title":"HPV test results stratify risk for histopathologic follow-up findings of high-grade cervical intra-epithelial neoplasia in women with low-grade squamous intra-epithelial lesion Pap results","volume":"55","author":"Heider\n              A,","year":"2011","unstructured":"Heider\n              A, \n            \n              Austin\n              RM, \n            \n              Zhao\n              C. \n          \n          HPV test results stratify risk for histopathologic follow-up findings of high-grade cervical intra-epithelial neoplasia in women with low-grade squamous intra-epithelial lesion Pap results. Acta Cytol. 2011;55(1):48\u201353."},{"issue":"10","key":"i1543-2165-137-2-214-b11","series-title":"Arch Pathol Lab Med","first-page":"1525","article-title":"The value of monitoring human papillomavirus DNA results for Papanicolaou tests diagnosed as atypical squamous cells of undetermined significance: a College of American Pathologists Q-Probes study of 68 institutions","volume":"131","author":"Tworek\n              JA,","year":"2007","unstructured":"Tworek\n              JA, \n            \n              Jones\n              BA, \n            \n              Raab\n              S, \n            \n              Clary\n              KM, \n            \n              Walsh\n              MK. \n          \n          The value of monitoring human papillomavirus DNA results for Papanicolaou tests diagnosed as atypical squamous cells of undetermined significance: a College of American Pathologists Q-Probes study of 68 institutions. Arch Pathol Lab Med. 2007;131(10):1525\u20131531."},{"issue":"2","key":"i1543-2165-137-2-214-b12","series-title":"Cancer","first-page":"67","article-title":"Testing for HPV as an objective measure for quality assurance in gynecologic cytology: positive rates in equivocal and abnormal specimens and comparison with the ASCUS to SIL ratio","volume":"111","author":"Ko\n              V,","year":"2007","unstructured":"Ko\n              V, \n            \n              Nanji\n              S, \n            \n              Tambouret\n              RH, \n            \n              Wilbur\n              DC. \n          \n          Testing for HPV as an objective measure for quality assurance in gynecologic cytology: positive rates in equivocal and abnormal specimens and comparison with the ASCUS to SIL ratio. Cancer. 2007;111(2):67\u201373."},{"issue":"4","key":"i1543-2165-137-2-214-b13","series-title":"J Natl Cancer Inst","first-page":"293","article-title":"Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial","volume":"93","author":"Solomon\n              D,","year":"2001","unstructured":"Solomon\n              D, \n            \n              Schiffman\n              M, \n            \n              Tarone\n              R. \n          \n          Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001;93(4):293\u2013299."},{"issue":"3","key":"i1543-2165-137-2-214-b14","series-title":"Br J Cancer","first-page":"511","article-title":"Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions","volume":"101","author":"Brismar-Wendel\n              S,","year":"2009","unstructured":"Brismar-Wendel\n              S, \n            \n              Froberg\n              M, \n            \n              Hjerpe\n              A, \n            \n              Andersson\n              S, \n            \n              Johansson\n              B. \n          \n          Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions. Br J Cancer. 2009;101(3):511\u2013517."},{"issue":"3","key":"i1543-2165-137-2-214-b15","series-title":"Eur J Cancer","first-page":"476","article-title":"HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology","volume":"43","author":"Ronco\n              G,","year":"2007","unstructured":"Ronco\n              G, \n            \n              Cuzick\n              J, \n            \n              Segnan\n              N, \n            et al\n          . HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology. Eur J Cancer. 2007;43(3):476\u2013480."},{"issue":"4","key":"i1543-2165-137-2-214-b16","series-title":"Am J Clin Pathol","first-page":"653","article-title":"The ASC\/SIL ratio for cytopathologists as a quality control measure: a follow-up study","volume":"128","author":"Nascimento\n              AF,","year":"2007","unstructured":"Nascimento\n              AF, \n            \n              Cibas\n              ES. \n          \n          The ASC\/SIL ratio for cytopathologists as a quality control measure: a follow-up study. Am J Clin Pathol. 2007;128(4):653\u2013656."},{"issue":"1","key":"i1543-2165-137-2-214-b17","series-title":"Am J Clin Pathol","first-page":"97","article-title":"Using the rate of positive high-risk HPV test results for ASC-US together with the ASC-US\/SIL ratio in evaluating the performance of cytopathologists","volume":"129","author":"Cibas\n              ES,","year":"2008","unstructured":"Cibas\n              ES, \n            \n              Zou\n              KH, \n            \n              Crum\n              CP, \n            \n              Kuo\n              F. \n          \n          Using the rate of positive high-risk HPV test results for ASC-US together with the ASC-US\/SIL ratio in evaluating the performance of cytopathologists. Am J Clin Pathol. 2008;129(1):97\u2013101."},{"key":"i1543-2165-137-2-214-b01","series-title":"Fed Regist","first-page":"7001","article-title":"Final Rule","volume":"57","year":"1992","unstructured":"Clinical Laboratory Improvement Amendments of 1988. Final Rule. Fed Regist. 1992;57:7001\u20137186. Current CLIA regulations (including all changes through 01\/24\/2004).http:\/\/www.phppo.cdc.gov\/clia\/regs\/toc.aspx. Accessed June 7, 2012."},{"issue":"4","key":"i1543-2165-137-2-214-b02","series-title":"J Low Genit Tract Dis","first-page":"201","article-title":"2006 consensus guidelines for the management of women with abnormal cervical screening tests","volume":"11","author":"Wright\n              TC\n              Jr,","year":"2007","unstructured":"Wright\n              TC\n              Jr, \n            \n              Massad\n              LS, \n            \n              Dunton\n              CJ, \n            \n              Spitzer\n              M, \n            \n              Wilkinson\n              EJ, \n            \n              Solomon\n              D. \n          \n          2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis. 2007;11(4):201\u2013222."},{"issue":"3","key":"i1543-2165-137-2-214-b03","series-title":"J Low Genit Tract Dis","first-page":"135","article-title":"Davis Davey D. Statement on HPV DNA test utilization","volume":"13","author":"Solomon\n              D,","year":"2009","unstructured":"Solomon\n              D, \n            \n              Papillo\n              J, \n          \n          Davis Davey D. Statement on HPV DNA test utilization. J Low Genit Tract Dis. 2009;13(3):135\u2013136."},{"issue":"2","key":"i1543-2165-137-2-214-b04","series-title":"Arch Pathol Lab Med","first-page":"158","article-title":"College of American Pathologists consensus conference on good laboratory practices in gynecologic cytology: background, rationale, and organization","volume":"137","author":"Tworek\n              JA,","year":"2013","unstructured":"Tworek\n              JA, \n            \n              Henry\n              M, \n            \n              Jones\n              BA. \n          \n          College of American Pathologists consensus conference on good laboratory practices in gynecologic cytology: background, rationale, and organization. Arch Pathol Lab Med. 2013;137(2):158\u2013163."},{"issue":"2","key":"i1543-2165-137-2-214-b05","series-title":"J Pediatr","first-page":"277","article-title":"The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women","volume":"132","author":"Moscicki\n              AB,","year":"1998","unstructured":"Moscicki\n              AB, \n            \n              Shiboski\n              S, \n            \n              Broering\n              J, \n            et al\n          . The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr. 1998;132(2):277\u2013284."},{"issue":"8","key":"i1543-2165-137-2-214-b06","series-title":"Diagn Cytopathol","first-page":"463","article-title":"A rock and a hard place: HPV testing and financial gain","volume":"35","author":"Moriarty\n              AT.","year":"2007","unstructured":"Moriarty\n              AT. \n          \n          A rock and a hard place: HPV testing and financial gain. Diagn Cytopathol. 2007;35(8):463\u2013464."},{"issue":"3","key":"i1543-2165-137-2-214-b07","series-title":"Obstet Gynecol","first-page":"595","article-title":"Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting","volume":"113","author":"Castle\n              PE,","year":"2009","unstructured":"Castle\n              PE, \n            \n              Fetterman\n              B, \n            \n              Poitras\n              N, \n            \n              Lorey\n              T, \n            \n              Shaber\n              R, \n            \n              Kinney\n              W. \n          \n          Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting. Obstet Gynecol. 2009;113(3):595\u2013600."},{"issue":"7","key":"i1543-2165-137-2-214-b08","series-title":"Ann Intern Med","first-page":"493","article-title":"Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003\u20132005","volume":"148","author":"Datta\n              SD,","year":"2008","unstructured":"Datta\n              SD, \n            \n              Koutsky\n              LA, \n            \n              Ratelle\n              S, \n            et al\n          . Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003\u20132005. Ann Intern Med. 2008;148(7):493\u2013500."},{"issue":"6","key":"i1543-2165-137-2-214-b09","series-title":"Am J Clin Pathol","first-page":"894","article-title":"High-risk HPV testing in women 30 years or older with negative Papanicolaou tests: initial clinical experience with 18-month follow-up","volume":"133","author":"Thrall\n              MJ,","year":"2010","unstructured":"Thrall\n              MJ, \n            \n              Russell\n              DK, \n            \n              Facik\n              MS, \n            et al\n          . High-risk HPV testing in women 30 years or older with negative Papanicolaou tests: initial clinical experience with 18-month follow-up. Am J Clin Pathol. 2010;133(6):894\u2013898."},{"issue":"1","key":"i1543-2165-137-2-214-b10","series-title":"Acta Cytol","first-page":"48","article-title":"HPV test results stratify risk for histopathologic follow-up findings of high-grade cervical intra-epithelial neoplasia in women with low-grade squamous intra-epithelial lesion Pap results","volume":"55","author":"Heider\n              A,","year":"2011","unstructured":"Heider\n              A, \n            \n              Austin\n              RM, \n            \n              Zhao\n              C. \n          \n          HPV test results stratify risk for histopathologic follow-up findings of high-grade cervical intra-epithelial neoplasia in women with low-grade squamous intra-epithelial lesion Pap results. Acta Cytol. 2011;55(1):48\u201353."},{"issue":"10","key":"i1543-2165-137-2-214-b11","series-title":"Arch Pathol Lab Med","first-page":"1525","article-title":"The value of monitoring human papillomavirus DNA results for Papanicolaou tests diagnosed as atypical squamous cells of undetermined significance: a College of American Pathologists Q-Probes study of 68 institutions","volume":"131","author":"Tworek\n              JA,","year":"2007","unstructured":"Tworek\n              JA, \n            \n              Jones\n              BA, \n            \n              Raab\n              S, \n            \n              Clary\n              KM, \n            \n              Walsh\n              MK. \n          \n          The value of monitoring human papillomavirus DNA results for Papanicolaou tests diagnosed as atypical squamous cells of undetermined significance: a College of American Pathologists Q-Probes study of 68 institutions. Arch Pathol Lab Med. 2007;131(10):1525\u20131531."},{"issue":"2","key":"i1543-2165-137-2-214-b12","series-title":"Cancer","first-page":"67","article-title":"Testing for HPV as an objective measure for quality assurance in gynecologic cytology: positive rates in equivocal and abnormal specimens and comparison with the ASCUS to SIL ratio","volume":"111","author":"Ko\n              V,","year":"2007","unstructured":"Ko\n              V, \n            \n              Nanji\n              S, \n            \n              Tambouret\n              RH, \n            \n              Wilbur\n              DC. \n          \n          Testing for HPV as an objective measure for quality assurance in gynecologic cytology: positive rates in equivocal and abnormal specimens and comparison with the ASCUS to SIL ratio. Cancer. 2007;111(2):67\u201373."},{"issue":"4","key":"i1543-2165-137-2-214-b13","series-title":"J Natl Cancer Inst","first-page":"293","article-title":"Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial","volume":"93","author":"Solomon\n              D,","year":"2001","unstructured":"Solomon\n              D, \n            \n              Schiffman\n              M, \n            \n              Tarone\n              R. \n          \n          Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001;93(4):293\u2013299."},{"issue":"3","key":"i1543-2165-137-2-214-b14","series-title":"Br J Cancer","first-page":"511","article-title":"Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions","volume":"101","author":"Brismar-Wendel\n              S,","year":"2009","unstructured":"Brismar-Wendel\n              S, \n            \n              Froberg\n              M, \n            \n              Hjerpe\n              A, \n            \n              Andersson\n              S, \n            \n              Johansson\n              B. \n          \n          Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions. Br J Cancer. 2009;101(3):511\u2013517."},{"issue":"3","key":"i1543-2165-137-2-214-b15","series-title":"Eur J Cancer","first-page":"476","article-title":"HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology","volume":"43","author":"Ronco\n              G,","year":"2007","unstructured":"Ronco\n              G, \n            \n              Cuzick\n              J, \n            \n              Segnan\n              N, \n            et al\n          . HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology. Eur J Cancer. 2007;43(3):476\u2013480."},{"issue":"4","key":"i1543-2165-137-2-214-b16","series-title":"Am J Clin Pathol","first-page":"653","article-title":"The ASC\/SIL ratio for cytopathologists as a quality control measure: a follow-up study","volume":"128","author":"Nascimento\n              AF,","year":"2007","unstructured":"Nascimento\n              AF, \n            \n              Cibas\n              ES. \n          \n          The ASC\/SIL ratio for cytopathologists as a quality control measure: a follow-up study. Am J Clin Pathol. 2007;128(4):653\u2013656."},{"issue":"1","key":"i1543-2165-137-2-214-b17","series-title":"Am J Clin Pathol","first-page":"97","article-title":"Using the rate of positive high-risk HPV test results for ASC-US together with the ASC-US\/SIL ratio in evaluating the performance of cytopathologists","volume":"129","author":"Cibas\n              ES,","year":"2008","unstructured":"Cibas\n              ES, \n            \n              Zou\n              KH, \n            \n              Crum\n              CP, \n            \n              Kuo\n              F. \n          \n          Using the rate of positive high-risk HPV test results for ASC-US together with the ASC-US\/SIL ratio in evaluating the performance of cytopathologists. Am J Clin Pathol. 2008;129(1):97\u2013101."}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/137\/2\/article-p214.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/137\/2\/article-p214.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/137\/2\/article-p214.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:57:33Z","timestamp":1770771453000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/137\/2\/article-p214.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":34,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.5858\/arpa.2012-0114-cp","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}